SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043697
Filing Date
2021-08-12
Accepted
2021-08-12 10:25:01
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gmtx-10q_20210630.htm   iXBRL 10-Q 2085692
2 EX-10.1 gmtx-ex101_146.htm EX-10.1 123102
3 EX-31.1 gmtx-ex311_10.htm EX-31.1 20061
4 EX-31.2 gmtx-ex312_9.htm EX-31.2 20039
5 EX-32.1 gmtx-ex321_8.htm EX-32.1 18631
  Complete submission text file 0001564590-21-043697.txt   6912846

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gmtx-20210630.xsd EX-101.SCH 57268
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gmtx-20210630_cal.xml EX-101.CAL 37176
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gmtx-20210630_def.xml EX-101.DEF 148904
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gmtx-20210630_lab.xml EX-101.LAB 386322
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gmtx-20210630_pre.xml EX-101.PRE 284932
11 EXTRACTED XBRL INSTANCE DOCUMENT gmtx-10q_20210630_htm.xml XML 1036537
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39438 | Film No.: 211165891
SIC: 2834 Pharmaceutical Preparations